TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

IN-BODY HOSPITALS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

IN-BODY HOSPITALS

ST13

US500000079259172

Classe

5, 10, 44

Pedido

79259172

Registro

5929512

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

32

Atualização mais recente

19/05/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 44

Data de depósito

24/01/2019

Data de registro

10/12/2019

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/04/2026

Última transação

19/05/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

708

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Kawasaki-shi Kanagawa, JP

Examinador

MCCLELLAN, MATTHEW D.

Localização atual

Historical data usage

Titulares e representantes

Titulares

KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION
KAWASAKI INSTITUTE OF INDUSTRIAL PROMOTION

Representantes

Bassam N. Ibrahim Buchanan Ingersoll & Rooney PC

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

[ Pharmaceutical preparations, namely, a drug delivery system comprising polymer micelle nanocarriers for targeted drug and gene delivery; pharmaceutical preparations, namely, an anticancer drug coated with polymer micelle; contrast media for use with MRI equipment; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents in the form of capsules, tablets or powders that facilitate the delivery of pharmaceutical preparations; pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral drug tablets, transdermal creams, compresses and patches for delivery of pharmaceuticals and injectable pharmaceuticals, all for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for cancer, brain tumor, Alzheimer, dementia, Parkinson's disease, hepatitis C, osteoarthritis, influenza, arteriosclerosis, spinal muscular atrophy, cerebral infarct, cerebral aneurysm, headache, epilepsy, ALS, myocardial infarction, angina, rheumatism, connective tissue disease, gout, measles, rubella, mumps, chickenpox, herpes zoster, tuberculosis, herpes, norovirus infection, hay fever and asthma; reagent paper for medical purposes ]

Classe 10

[ Medical and diagnostic instruments made from organic compounds which circulate in the blood, accumulate at disease sites, such as cancer, and treat them; medical instruments made from organic or inorganic compounds which capture chemical and physical information from a disease site and bring it to an analyzer; MRI apparatus for medical purposes; MRI apparatus for medical purposes made from organic compounds; drug delivery systems; medical diagnostic apparatus for testing cancer cells; medical robots patrolling the microenvironment, detecting diseases and treating them in the body ]

Classe 44

Medical services; provision of medical information; provision of medical information relating to pharmaceuticals; [ providing information relating to the rental of medical machines and apparatus; ] medical, medicinal and pharmaceutical consultancy [ ; medical equipment rental ]

Publicações

Histórico de despachos e eventos da marca no USPTO.

32 publicações encontradas

NA75

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED

24/04/2026

C75P

REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.

24/04/2026

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

24/04/2026

PR75

POST REGISTRATION ACTION MAILED - SEC. 71 & 15

30/01/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

26/01/2026

ES75

TEAS SECTION 71 & 15 RECEIVED

25/09/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/12/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

29/05/2020

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

24/03/2020

XXCR

GENERIC MADRID TRANSACTION CREATED

24/03/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/03/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

10/12/2019

GPNX

NOTIFICATION PROCESSED BY IB

05/10/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

24/09/2019

PUBO

PUBLISHED FOR OPPOSITION

24/09/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

18/09/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

18/09/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/09/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

20/08/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/08/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/08/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/08/2019

RFNT

REFUSAL PROCESSED BY IB

12/07/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

24/06/2019

RFRR

REFUSAL PROCESSED BY MPU

24/06/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

04/06/2019

CNRT

NON-FINAL ACTION WRITTEN

03/06/2019

MAFR

APPLICATION FILING RECEIPT MAILED

01/06/2019

DOCK

ASSIGNED TO EXAMINER

28/05/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

28/05/2019

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

25/05/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

23/05/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace IN-BODY HOSPITALS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.